Physiological and pharmacological implications of AT1 versus AT2 receptors
Physiological and pharmacological implications of AT1 versus AT2 receptors
复制标题
DOI:
10.1046/j.1523-1755.1998.06719.x
复制
发表时间:
1998-09-01
影响因子:
19.6
通讯作者:
Unger, T
中科院分区:
文献类型:
--
作者:
Chung, O;Kühl, H;Unger, T
Angiotensin II (Ang II) has diverse physiological actions that lead, for instance, to increases in extracellular volume and peripheral vascular resistance and blood pressure, and it has also been implicated in the regulation of cell growth and differentiation. Molecular cloning and pharmacological studies have defined two major classes of Ang II receptors, designated AT, and AT(2). Most effects of Ang II are mediated by AT(1) receptors. Much less is known about the physiological role of AT(1) receptors. Recent evidence suggests involvement of AT(2) receptors in development, cell differentiation, apoptosis, and regeneration in various tissues. AT(1) and AT(2) receptors have been shown to exert counteracting effects on cellular growth and differentiation, vascular tone, and the release of arginine vasopressin. In each condition, the AT(2) receptor appears to down-modulate actions mediated by the AT(1) receptor, resulting in decreased cellular proliferation, decreased levels of serum arginine vasopressin levels, or decreased vasoconstrictor responses. In addition, in neuronal cell lines, the AT(2) receptor exerts antiproliferative actions and promotes neurite outgrowth, an effect accompanied by significant changes in the expression pattern of growth/differentiation-related genes.